Industry · Pharma
AI messaging governance for medical, MLR, and commercial teams
On-label claims, MLR-aligned messaging, and adverse-event flagging on every AI-generated medical and commercial communication.
in DOJ off-label promotion settlements over the past decade
DOJ
governs every interaction with HCPs, including AI-drafted materials
PhRMA
to report a serious adverse event - AI-surfaced AE signals must route immediately
FDA 21 CFR 314.80
The governance gap
AI doesn't know what's on label. It needs to be told.
LLMs cheerfully extend indications, dosing, and populations - language that maps directly to False Claims Act and DOJ off-label exposure. MLR review wasn't built for the volume AI now generates.
Message.inc enforces on-label claims, routes everything HCP- or patient-facing through MLR, and runs an adverse-event classifier on any AI processing of patient or HCP text.
Off-label drift in commercial copy
AI happily extends indications, populations, and dosing in ways that map directly to False Claims Act exposure.
MLR bottleneck breakage
Teams routing around Medical-Legal-Regulatory review with AI shortcuts create unreviewed assets with the company's name on them.
Missed adverse events
AI processing HCP or patient messages without an AE detection step turns reportable signals into invisible ones.
Fair-balance and ISI handling
Important Safety Information must travel with every claim. AI drafts routinely omit, summarize, or de-emphasize it.
Pre-built policy pack
On-label, MLR-aligned policies for every AI output
Pre-built rules covering label adherence, fair balance, PV signal routing, and full MLR auditability - applied across medical, commercial, and field teams.
- LABEL-01On-label claim enforcementAI-generated commercial copy is checked against the approved label. Off-label language is blocked, not warned.
- MLR-01MLR routing requiredAll HCP- and patient-facing AI drafts route through MLR with full prompt, output, and reviewer trail.
- AE-01Adverse event detectionAny AI processing of HCP or patient text runs an AE classifier and routes positives to PV within 24 hours.
- ISI-01Fair balance enforcementISI and indication statements must appear with every promotional claim. Drafts without them are blocked.
Where Message.inc sits
Where Message.inc fits in pharma workflows
Get governance live before the next OPDP letter
OPDP enforcement is back to pre-pandemic cadence and the surface area now includes every AI tool your reps and MSLs use. Close the gap before it becomes a warning letter.
We're onboarding a small cohort of pharma early adopters. Get early access and we'll reach out within a few days.
Early access
No credit card. Enterprise-ready terms.
Sources & further reading